Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Gattinoni

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
The Journal of Experimental Medicine|October 28, 2015
Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infectionKyla D Omilusik, J Adam Best, Bingfei Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2008
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunityDouglas C Palmer, Chi-Chao Chan, Luca Gattinoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2004
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cellsChristopher A Klebanoff, Steven E Finkelstein, Deborah R Surman, et al.
Journal of Leukocyte Biology|May 25, 2004
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancerSteven E Finkelstein, David M Heimann, Christopher A Klebanoff, et al.
Oncoimmunology|October 6, 2018
<i>Ex vivo</i> AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8<sup>+</sup> T cells for adoptive immunotherapyCharlotte M Mousset, Willemijn Hobo, Yun Ji, et al.
Cellular & Molecular Immunology|April 28, 2015
Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscapeJoseph G Crompton, Manikandan Narayanan, Suresh Cuddapah, et al.
Vaccine|December 3, 2014
Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiationRahul Roychoudhuri, Francois Lefebvre, Mitsuo Honda, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokinesYun Ji, Claudia Wrzesinski, Zhiya Yu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studiesSid P Kerkar, Luis Sanchez-Perez, Shicheng Yang, et al.
Blood|October 23, 2014
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapyAnniek B van der Waart, Noortje M P van de Weem, Frans Maas, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
The Journal of Experimental Medicine|October 28, 2015
Transcriptional repressor ZEB2 promotes terminal differentiation of CD8+ effector and memory T cell populations during infectionKyla D Omilusik, J Adam Best, Bingfei Yu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 5, 2008
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunityDouglas C Palmer, Chi-Chao Chan, Luca Gattinoni, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2004
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cellsChristopher A Klebanoff, Steven E Finkelstein, Deborah R Surman, et al.
Journal of Leukocyte Biology|May 25, 2004
Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancerSteven E Finkelstein, David M Heimann, Christopher A Klebanoff, et al.
Oncoimmunology|October 6, 2018
<i>Ex vivo</i> AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8<sup>+</sup> T cells for adoptive immunotherapyCharlotte M Mousset, Willemijn Hobo, Yun Ji, et al.
Cellular & Molecular Immunology|April 28, 2015
Lineage relationship of CD8(+) T cell subsets is revealed by progressive changes in the epigenetic landscapeJoseph G Crompton, Manikandan Narayanan, Suresh Cuddapah, et al.
Vaccine|December 3, 2014
Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiationRahul Roychoudhuri, Francois Lefebvre, Mitsuo Honda, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2014
miR-155 augments CD8+ T-cell antitumor activity in lymphoreplete hosts by enhancing responsiveness to homeostatic γc cytokinesYun Ji, Claudia Wrzesinski, Zhiya Yu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 19, 2011
Genetic engineering of murine CD8+ and CD4+ T cells for preclinical adoptive immunotherapy studiesSid P Kerkar, Luis Sanchez-Perez, Shicheng Yang, et al.
Blood|October 23, 2014
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapyAnniek B van der Waart, Noortje M P van de Weem, Frans Maas, et al.
Pageof 12